Delegation of Authority, 61252 [2021-24249]
Download as PDF
61252
Federal Register / Vol. 86, No. 212 / Friday, November 5, 2021 / Notices
regulations at 42 CFR 71.4, 71.20, 71.31,
and 71.32.
Sherri Berger,
Chief of Staff, Centers for Disease Control
and Prevention.
[FR Doc. 2021–24386 Filed 11–3–21; 4:15 pm]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Delegation of Authority
Notice is hereby given that pursuant
to Section 222 of the Public Health
Service Act [42 U.S.C. 217a], as
amended, I have delegated to the
Director, Centers for Disease Control
and Prevention (CDC), authority to
appoint temporary members to the
National Institute for Occupational
Safety and Health’s Safety and
Occupational Health Study Section
(SOHSS). This authority may be
redelegated by the CDC Director.
This delegation supersedes the June 7,
2016, delegation concerning this
authority.
This delegation became effective upon
date of signature. In addition, I affirmed
and ratified any actions taken by the
Director, CDC or her subordinates that
involved the exercise of the authorities
delegated herein, or substantially
similar authorities vested in me by prior
annual HHS appropriations acts, prior
to the effective date of the delegation.
Dated: November 2, 2021.
Xavier Becerra,
Secretary.
[FR Doc. 2021–24249 Filed 11–4–21; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
jspears on DSK121TN23PROD with NOTICES1
Centers for Disease Control and
Prevention
Requirement for Negative PreDeparture COVID–19 Test Result or
Documentation of Recovery From
COVID–19 for All Airline or Other
Aircraft Passengers Arriving Into the
United States From Any Foreign
Country
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of agency amended
order.
VerDate Sep<11>2014
21:40 Nov 04, 2021
Jkt 256001
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces an
Amended Order requiring negative predeparture COVID–19 test results or
documentation of recovery from
COVID–19 for all airline or other aircraft
passengers arriving into the United
States from any foreign country. This
Amended Order was signed by the CDC
Director on October 25, 2021, and
supersedes the previous Order signed by
the CDC Director on January 25, 2021.
DATES: This Amended Order will
become effective at 12:01 a.m. on
November 8, 2021.
FOR FURTHER INFORMATION CONTACT:
Jennifer Buigut, Division of Global
Migration and Quarantine, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H16–4, Atlanta,
GA 30329. Telephone: 404–498–1600.
Email: dgmqpolicyoffice@cdc.gov.
SUPPLEMENTARY INFORMATION: This
Amended Order updates COVID–19
testing requirements for air passengers 2
years of age and older boarding a flight
to the United States, depending on their
COVID–19 vaccination status.
This Amended Order prohibits the
boarding of any passenger 2 years of age
and older on any airline or aircraft
destined to the United States from a
foreign country unless the passenger
presents:
(1) Paper or digital documentation of
a negative pre-departure viral test result
for SARS–CoV–2, the virus that causes
COVID–19, that meets one of the
following requirements:
• For passengers who are fully
vaccinated against COVID–19, the viral
test must be conducted on a specimen
collected no more than 3 days before the
flight’s departure from a foreign
country.
• For passengers not fully vaccinated
against COVID–19, the viral test must be
conducted on a specimen collected no
more than 1 day before the flight’s
departure from a foreign country.
Or
(2) Paper or digital documentation of
recovery from COVID–19 in the form of
both:
• A positive viral test result
conducted on a specimen collected no
more than 90 days before the flight; and
• A letter from a licensed health care
provider or public health official stating
that the passenger has been cleared for
travel.
This Amended Order also constitutes
a controlled free pratique to any airline
or other aircraft operator with an aircraft
arriving into the United States. Pursuant
to this controlled free pratique, the
SUMMARY:
PO 00000
Frm 00140
Fmt 4703
Sfmt 4703
airline or other aircraft operator must
comply with the requirements outlined
in the Amended Order.
A copy of the Amended Order and
Passenger Attestation form is provided
below. A copy of the signed Amended
Order and Passenger Attestation form
can be found at https://www.cdc.gov/
quarantine/fr-proof-negative-test.html.
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS)
Notice and Amended Order Under
Section 361 of the Public Health Service
Act (42 U.S.C. 264) and 42 Code of
Federal Regulations 71.20 & 71.31(b)
Requirement for Negative PreDeparture COVID–19 Test Result or
Documentation of Recovery From
COVID–19 for All Airline or Other
Aircraft Passengers Arriving Into the
United States From Any Foreign
Country
Summary
Pursuant to 42 CFR 71.20, 71.31(b)
and as set forth in greater detail below,
this Notice and Amended Order 1
prohibits the boarding of any
passenger—2 years of age or older—on
any aircraft destined to the United
States 2 from a foreign country unless
the passenger 3 presents:
(1) Paper or digital documentation of
a negative pre-departure viral test result
for SARS–CoV–2, the virus that causes
COVID–19, that meets one of the
following requirements:
• For passengers who are fully
vaccinated against COVID–19, the viral
test must be conducted on a specimen
collected no more than 3 calendar days
before the flight’s departure from a
foreign country (Qualifying Test for
Fully Vaccinated).
• For passengers who are not fully
vaccinated against COVID–19, the viral
test must be conducted on a specimen
collected no more than 1 calendar day
before the flight’s departure from a
foreign country (Qualifying Test for Not
Fully Vaccinated).
Or
(2) Paper or digital documentation of
recovery from COVID–19 in the form of
both:
1 This Amended Order supersedes the previous
order signed by the Centers for Disease Control and
Prevention (CDC) Director on January 25, 2021.
2 This includes any flight, regardless of whether
the United States is final destination or connection
to another country.
3 A parent or other authorized individual may
present the required documentation on behalf of a
passenger 2–17 years of age. An authorized
individual may act on behalf of any passenger who
is unable to act on their own behalf (e.g., by reason
of age, or physical or mental impairment).
E:\FR\FM\05NON1.SGM
05NON1
Agencies
[Federal Register Volume 86, Number 212 (Friday, November 5, 2021)]
[Notices]
[Page 61252]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-24249]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Delegation of Authority
Notice is hereby given that pursuant to Section 222 of the Public
Health Service Act [42 U.S.C. 217a], as amended, I have delegated to
the Director, Centers for Disease Control and Prevention (CDC),
authority to appoint temporary members to the National Institute for
Occupational Safety and Health's Safety and Occupational Health Study
Section (SOHSS). This authority may be redelegated by the CDC Director.
This delegation supersedes the June 7, 2016, delegation concerning
this authority.
This delegation became effective upon date of signature. In
addition, I affirmed and ratified any actions taken by the Director,
CDC or her subordinates that involved the exercise of the authorities
delegated herein, or substantially similar authorities vested in me by
prior annual HHS appropriations acts, prior to the effective date of
the delegation.
Dated: November 2, 2021.
Xavier Becerra,
Secretary.
[FR Doc. 2021-24249 Filed 11-4-21; 8:45 am]
BILLING CODE 4160-18-P